References
- Jacobson IM, Davis GL, El-Serag H, Negro F, Trepo C. Prevalence and challenges of liver diseases in patients with chronic hepatitis C virus infection. Clin Gastroenterol Hepatol 2010;8:924–33.
- Hoofnagle JH. Course and outcome of hepatitis C. Hepatology 2002;36:S21–9.
- Zhang M, Rosenberg PS, Brown DL, Preiss L, Konkle BA, Eyster ME, . Correlates of spontaneous clearance of hepatitis C virus among people with hemophilia. Blood 2006;107:892–7.
- Sulkowski MS. Viral hepatitis and HIV coinfection. J Hepatol 2008;48:353–67.
- Bruno R, Sacchi P. Spontaneous hepatitis C virus clearance in HIV-infected patients: new insights for improving management. J Infect Dis 2008;198:1262–4.
- Thomas DL, Astemborski J, Rai RM, Anania FA, Schaeffer M, Galai N, . The natural history of hepatitis C virus infection: host, viral, and environmental factors. JAMA 2000;284:450–6.
- Soriano V, Mocroft A, Rockstroh J, Ledergerber B, Knysz B, Chaplinskas S, . Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe. J Infect Dis 2008;198:1337–44.
- Hansen N, Obel N, Christensen PB, Krarup H, Laursen AL, Clausen MR, . Predictors of antiviral treatment initiation in hepatitis C virus-infected patients: a Danish cohort study. J Viral Hepat 2009;16:659–65.
- Krarup HB, Drewes AM, Madsen PH. A quantitative HCV-PCR test for routine diagnostics. Scand J Clin Lab Invest 1998;58:415–22.
- Gottwein JM, Scheel TK, Hoegh AM, Lademann JB, Eugen-Olsen J, Lisby G, . Robust hepatitis C genotype 3a cell culture releasing adapted intergenotypic 3a/2a (S52/JFH1) viruses. Gastroenterology 2007;133:1614–26.
- Pittaluga F, Allice T, Abate ML, Ciancio A, Cerutti F, Varetto S, . Clinical evaluation of the COBAS Ampliprep/COBAS TaqMan for HCV RNA quantitation in comparison with the branched-DNA assay. J Med Virol 2008;80: 254–60.
- Krarup HB, Moller JM, Christensen PB, Fuglsang T, Ingerslev J, Arnfred T, . Haemophilic patients with hepatitis C have higher viral load compared to other well-defined patient groups. J Viral Hepat 2000;7:435–9.
- Murphy DG, Willems B, Deschenes M, Hilzenrat N, Mousseau R, Sabbah S. Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5′ untranslated region sequences. J Clin Microbiol 2007;45:1102–12.
- Nascimbeni M, Mizukoshi E, Bosmann M, Major ME, Mihalik K, Rice CM, . Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees. J Virol 2003;77:4781–93.
- Kamal SM, Amin A, Madwar M, Graham CS, He Q, Al Tawil A, . Cellular immune responses in seronegative sexual contacts of acute hepatitis C patients. J Virol 2004;78:12252–8.
- Major ME, Mihalik K, Puig M, Rehermann B, Nascimbeni M, Rice CM, . Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge. J Virol 2002;76:6586–95.
- Busch MP, Glynn SA, Stramer SL, Orland J, Murphy EL, Wright DJ, . Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors. Transfusion 2006;46:469–75.
- Deterding K, Tegtmeyer B, Cornberg M, Hadem J, Potthoff A, Boker KH, . Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV. J Hepatol 2006;45:770–8.
- Guidotti LG, Chisari FV. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001;19:65–91.
- Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am J Public Health 1996;86:655–61.
- Villano SA, Vlahov D, Nelson KE, Lyles CM, Cohn S, Thomas DL. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland. J Clin Microbiol 1997;35:3274–7.
- Nunez M, Soriano V. Hepatitis C virus (HCV) genotypes and disease progression in HIV/HCV-coinfected patients. J Infect Dis 2005;191:1–3.
- Lehmann M, Meyer MF, Monazahian M, Tillmann HL, Manns MP, Wedemeyer H. High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection. J Med Virol 2004;73:387–91.
- Thomson EC, Fleming VM, Main J, Klenerman P, Weber J, Eliahoo J, . Predicting spontaneous clearance of acute hepatitis C virus in a large cohort of HIV-1-infected men. Gut 2011;60:837–45.
- McKiernan SM, Hagan R, Curry M, McDonald GS, Kelly A, Nolan N, . Distinct MHC class I and II alleles are associated with hepatitis C viral clearance, originating from a single source. Hepatology 2004;40:108–14.
- Thio CL, Gao X, Goedert JJ, Vlahov D, Nelson KE, Hilgartner MW, . HLA-Cw*04 and hepatitis C virus persistence. J Virol 2002;76:4792–7.
- Rauch A, Kutalik Z, Descombes P, Cai T, di Iulio J, Mueller T, . Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study. Gastroenterology 2010;138:1338–45.
- Clausen LN, Weis N, Astvad K, Schonning K, Fenger M, Krarup H, . Interleukin-28B polymorphisms are associated with hepatitis C virus clearance and viral load in a HIV-1-infected cohort. J Viral Hepat 2011;18:e66–74.
- Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, . Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 2009;461:798–801.